Abstract
Control of vascular cell growth responses is critical for development and maintenance of a healthy vasculature. Connexins - the proteins comprising gap junction channels - are key regulators of cell growth in diseases such as cancer, but their involvement in controlling cell growth in the vasculature is less well appreciated. Connexin37 (Cx37) is one of four connexin isotypes expressed in the vessel wall. Its primary role in blood vessels relies on its unique ability to transduce flow-sensitive signals into changes in cell cycle status of endothelial (and perhaps, mural) cells. Here, we review available evidence for Cx37's role in the regulation of vascular growth, vessel organization, and vascular tone in healthy and diseased vasculature. We propose a novel mechanism whereby Cx37 accomplishes this with a phosphorylation-dependent transition between closed (growth-suppressive) and multiple open (growth-permissive) channel conformations that result from interactions of the C-terminus with cell-cycle regulators to limit or support cell cycle progression. Lastly, we discuss Cx37 and its downstream signaling as a novel potential target in the treatment of cardiovascular disease, and we address outstanding research questions that still challenge the development of such therapies.
Original language | English (US) |
---|---|
Pages (from-to) | 73-86 |
Number of pages | 14 |
Journal | Journal of Vascular Research |
Volume | 60 |
Issue number | 2 |
DOIs | |
State | Published - Sep 1 2023 |
Keywords
- Blood vessels
- Connexin37
- Cx37
- Gap junctions
- Vasculogenesis
- Vessel remodeling
ASJC Scopus subject areas
- Physiology
- Cardiology and Cardiovascular Medicine